Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment
Sponsor study identifier
interventional
37
1 country
6
Study Start
January 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 22, 2007
Actual (reported)January 2008
Date type not reportedThis date has not been verified as actual or estimated.
January 3, 2008
Actual (reported)October 2008
Actual (reported)October 2008
Actual (reported)Blood concentrations of the active ingredients and metabolites of ABT-335 and rosuvastatin
Days 1, 8, 9, and 10
Safety and tolerability of the study drugs
Study duration
45 mg once daily for 10 consecutive days
10 mg once daily for 10 days
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Site Reference ID/Investigator# 6610
Gainesville, Florida, 32608, United States
Site Reference ID/Investigator# 6738
Miami, Florida, 33136, United States
Site Reference ID/Investigator# 7723
Minneapolis, Minnesota, 55404, United States
Site Reference ID/Investigator# 7319
Knoxville, Tennessee, 37920, United States
Site Reference ID/Investigator# 6928
San Antonio, Texas, 78209, United States
Site Reference ID/Investigator# 8280
Richmond, Virginia, 23298-0160, United States
Torbjörn Lundström, MD
AstraZeneca
37 participants (actual enrollment reported by the registry).
First Submitted
December 22, 2007
First Posted
January 3, 2008
Study Start
January 2008
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)Last Updated
September 28, 2012
Record last verified: 2012-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: